ARROW Pharma, in consultation with the Therapeutic Goods Administration, has issued a product defect alert for one batch of Valpam 5 (diazepam) due to the possibility of the blister strip including white Valpam 2mg tablets, instead of yellow Valpam 5mg tablets.
The affected batch, which is numbered CP218, contains Valpam 5mg tablet blister packs (50 tablets) with an expiry date of Jan 2021.
The TGA said the alert follows one instance where a single Valpam 2mg tablet was found in a blister pack of Valpam 5mg tablets.
No other batches are known to be affected, with Arrow advising consumers and health professionals to visually inspect blisters from batch CP218 before dispensing or use to ensure all the tablets in a given blister are light yellow.
The correct tablets will also be marked with "DZ 5" on one side but this will only be visible if the numbered side faces the blister.
If no anomalies are found, the product may continue to be supplied and used as normal.
Consumers are advised to return any affected blisters unopened for refund or replacement.
More info from Arrow Pharma on 1800 941 148.
The above article was sent to subscribers in Pharmacy Daily's issue from 06 Jun 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 06 Jun 18
